| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.1 |